Glytec Awarded Patent Allowance for Virtual Insulin Titration in Concert with CGM, Smart Pens and Other Diabetes Technologies
MAY 16, 2019 Glytec Awarded Patent Allowance for Virtual Insulin Titration in Concert with CGM, Smart Pens and Other Diabetes Technologies The company’s growing intellectual property portfolio attests to its leadership position in diabetes medication optimization in an era of data-driven care. Waltham, MA — Glytec, the pioneer of digital therapeutics, has been awarded another patent allowance by...
Read More